Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)

Sponsor
Frederick Schmitt (Other)
Overall Status
Completed
CT.gov ID
NCT00040378
Collaborator
National Institute on Aging (NIA) (NIH), National Cancer Institute (NCI) (NIH)
4,246
91
171
46.7
0.3

Study Details

Study Description

Brief Summary

The Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE) prevention trial is an important addition to the Selenium and Vitamin E Cancer Prevention Trial (SELECT). As a prevention trial, PREADVISE is trying to find out if taking selenium and/or Vitamin E supplements can help to prevent memory loss and dementia such as Alzheimer's disease.

Condition or Disease Intervention/Treatment Phase

Detailed Description

Studies show that increased oxidative stress (from excess free radicals) may damage brain cells and is linked with Alzheimer's disease (AD). Many studies show increased oxidation of brain lipids (fats), proteins, carbohydrates (sugars) and DNA in AD. Although the causes of AD are not known, it is believed that oxidative stress is part of what damages brain cells in AD and probably other brain diseases. Animal and tissue culture studies of vitamin E and selenium suggest that they can protect brain cells from damage. This research study is being done to see how safe and effective vitamin E and selenium may be in preventing AD and other brain illnesses. These illnesses are more common in people over the age of 60 to 65. A potential benefit of participating in the PREADVISE study is that early detection of memory changes can lead to early diagnosis and treatment. Also, some participants may decrease their risk of getting AD if the supplements are effective. The findings of this study may also help in the research and understanding of AD.

Only participants who are taking part in the SELECT study (a study that looks at the use of vitamin E and selenium for preventing prostate cancer) may apply to participate in the PREADVISE study about how useful vitamin E and selenium might be for preventing memory changes with age (including Alzheimer's disease and other disease that can affect the brain). African American and Hispanic men who are age 60 or older may take part. Men of other ethnic groups aged 62 or older may take part. The SELECT doctors or staff will review the applicant's medical history and drugs to verify that they have no conditions that would exclude them from this study. About 10,000 men will take part in this study.

The PREADVISE study examinations will be done during the participant's annual SELECT visit at the clinic where the SELECT studies are being conducted. There will be one study visit for each year the participants are in SELECT (7 to 12 visits). Each visit for PREADVISE will consist of a brief screening of the participant's memory, and an update (if any) of the participant's family history of dementia and medications. If memory changes are suggested by the brief memory screen, the participant will be asked to take a longer memory screen to further evaluate the potential for memory changes. If the longer memory screen also suggests problems with the participant's memory, the participant will be asked to see his family doctor or a PREADVISE doctor for a more complete medical exam to find the possible causes of the memory change. Results of the doctor's medical exam, with the consent of the participant, will be sent to the PREADVISE doctors for their review to help with the diagnosis. Results of the memory checks will not be given to the participants. However, if the participant does have a medical workup for memory changes, this information will be given to the family doctor after the medical workup is completed. A portion of the blood sample that was taken when the participant entered SELECT might be analyzed and tested for a genetic risk factor associated with Alzheimer's disease, called Apolipoprotein E (ApoE). The results of this test will be used for research purposes only.

Study Design

Study Type:
Observational
Actual Enrollment :
4246 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
Actual Study Start Date :
May 1, 2002
Actual Primary Completion Date :
Jan 1, 2014
Actual Study Completion Date :
Aug 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Combination therapy

vitamin E (alphatocopherol) and selenium

Drug: alphatocopherol
400 IU daily
Other Names:
  • Vitamin E
  • Drug: Selenium
    200mcg daily

    Vitamin E only

    vitamine E (alphatocopherol) and placebo

    Drug: alphatocopherol
    400 IU daily
    Other Names:
  • Vitamin E
  • Drug: Placebo replacement for Selenium
    1 placebo pill daily

    Selenium only

    selenium and placebo (Placebo replacement for vitamin E)

    Drug: Selenium
    200mcg daily

    Drug: Placebo replacement for vitamin E
    1 placebo pill daily

    Placebo

    placebo (Placebo replacement for vitamin E) and placebo (Placebo replacement for selenium)

    Drug: Placebo replacement for vitamin E
    1 placebo pill daily

    Drug: Placebo replacement for Selenium
    1 placebo pill daily

    Outcome Measures

    Primary Outcome Measures

    1. incidence of dementia (including Alzheimer's disease) [7 to 12 years (depending on enrollment date)]

      Participants will complete a modified Telephone Interview of Cognitive Status (TIC-S) to evaluate the onset of dementia

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    60 Years to 90 Years
    Sexes Eligible for Study:
    Male
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Participating in SELECT Prevention study;

    • 62 years or older if other ethnic origin, or 60 years or older if African-American or Hispanic;

    • General good health with no neurological or psychiatric illness.

    Exclusion Criteria:

    The SELECT doctors or staff will review the PREADVISE applicants' medical history and drugs to verify that they have no condition(s) that would exclude them from this study. The participant must not have any of the following neurological conditions based on self report (were told by a physician):

    • Alzheimer's disease, or any other form of dementia such as Pick's disease, dementia with Lewy bodies, frontotemporal dementia, vascular dementia, significant cognitive and motor impairment from a stroke or corticobasal degeneration;

    • Huntington's disease, epilepsy, Parkinson's disease, brain tumor, multiple sclerosis, manic-depressive disorder, or schizophrenia;

    • The participant must not have had a head injury with prolonged loss of consciousness (over 30 minutes) within the past five years;

    • The participant must not have a current alcohol or substance abuse diagnosis, or must have been treatment free for the past 24 months;

    • The participant must not have had a diagnosis of depression or anxiety disorder in the past 4 months and must not currently be under treatment for depression or anxiety disorder. [A participant who was previously diagnosed with depression or anxiety disorder but completed treatment more than four months ago is eligible.];

    • The participant must not currently use of any of the following medications: Aricept, Cognex, Exelon, Reminyl, or Hydergine;

    • The participant must not have blindness, deafness, language difficulties or any other disability that may prevent completion of the memory screen.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Alabama at Birmingham Preventive Medicine Birmingham Alabama United States 35294-4410
    2 Alaska Regional Hospital Anchorage Alaska United States 99508
    3 Providence Alaska Medical Center Anchorage Alaska United States 99508
    4 University of California, San Diego - Chula Vista Chula Vista California United States 91910
    5 Glendale Memorial Hospital Glendale California United States 91204
    6 University of California, San Diego La Jolla California United States 92037-1709
    7 VA Medical Center Loma Linda California United States 92354-3866
    8 VAMC Long Beach Long Beach California United States 90822
    9 Northridge Hospital Medical Center Northridge California United States 91328
    10 Santa Rosa Memorial Hospital Regional CCOP Santa Rosa California United States 95403
    11 LABIOMED (Los Angeles Biomedical) Research Institute at Harbor-UCLA Medical Center Torrance California United States 90502-2064
    12 Lionel B. Katchem Upland California United States 91786
    13 Rocky Mountain CC/Poudre Valley Hospital Fort Collins Colorado United States 80524
    14 Sibley Memorial Hospital Washington District of Columbia United States 20016
    15 George Washington University Medical Center Washington District of Columbia United States 20037
    16 DC United MBCCOP Washington District of Columbia United States 20060-0001
    17 Baptist Medical Center Jacksonville Florida United States 32207-8560
    18 Kaiser Southeast Permanente Medical Group Tucker Georgia United States 30084
    19 Bliss Cancer Center/McFarland Clinic/Mary Greely MC Ames Iowa United States 50010
    20 Cedar Rapids CCOP Cedar Rapids Iowa United States 52403
    21 Genesis Medical Center Davenport Iowa United States 52804
    22 Iowa Oncology Research Association Des Moines Iowa United States 50309-1016
    23 Siouxland Hematology-Oncology Associates Sioux City Iowa United States 51101
    24 University of Kansas Medical Center Kansas City Kansas United States 66160
    25 Stormont-Vail Health Care/Cotton O'Neil Clinic Topeka Kansas United States 66606
    26 Wichita CCOP Wichita Kansas United States 67214-3882
    27 Our Lady of Bellefonte Hospital Inc. Ashland Kentucky United States 41101
    28 University of Kentucky Medical Center Lexington Kentucky United States 40536-0093
    29 Louisville VA Medical Center Louisville Kentucky United States 40206-1499
    30 Anne Arundel Medical Center Annapolis Maryland United States 21401-2777
    31 Berkshire Hematology Oncology/Bershire Medical Center Pittsfield Massachusetts United States 01201
    32 Bixby Oncology Center Adrian Michigan United States 49221
    33 Henry Ford Hospital Detroit Michigan United States 48202
    34 Grand Rapids Clinical Oncology Program CCOP Grand Rapids Michigan United States 49503-2560
    35 Monroe Clinic Monroe Michigan United States 48162
    36 St. Joseph Mercy Oakland Pontiac Michigan United States 48341
    37 Munson Medical Center Traverse City Michigan United States 49684-2386
    38 Duluth CCOP Duluth Minnesota United States 55805
    39 St. John's Regional Medical Center Joplin Missouri United States 64804
    40 St. John's Health System Springfield Missouri United States 65804
    41 Cancer Research for the Ozarks Springfield Missouri United States 65807
    42 Montana Cancer Consortium CCOP Billings Montana United States 59101
    43 Benefis Health Care Great Falls Montana United States 59405
    44 Good Samaritan Health Systems - Cancer Center Kearney Nebraska United States 68847
    45 Cancer Resource Center Lincoln Nebraska United States 68510-4844
    46 Alegent Health Immanuel Medical Center Omaha Nebraska United States 68122
    47 Alegent Health Bergan Mercy Medical Center Omaha Nebraska United States 68124
    48 Missouri Valley Cancer Cons CCOP/Creighton University Omaha Nebraska United States 68131
    49 Washoe Medical Center Reno Nevada United States 89520
    50 VAMC New Jersey Health Care System East Orange New Jersey United States 07018-1095
    51 Warren Hospital Phillipsburg New Jersey United States 08865
    52 Riverview Medical Center Red Bank New Jersey United States 07701
    53 Stratton Veterans Affairs Medical Center Albany New York United States 12208
    54 Bassett Research Institute Cooperstown New York United States 13326-1394
    55 Glens Falls Hospital Glens Falls New York United States 12801
    56 Good Samaritan Hospital Cincinnati Ohio United States 45220-2489
    57 Columbus CCOP Columbus Ohio United States 43206
    58 Fremont Memorial Hospital Fremont Ohio United States 43420
    59 NW Ohio Oncology Center/St. Luke's Hospital Maumee Ohio United States 43537
    60 St. Charles Hospital Oregon Ohio United States 43616
    61 Flower Hospital Sylvania Ohio United States 43560-2197
    62 Toledo Hospital Toledo Ohio United States 43606
    63 St. Vincent Medical Center Toledo Ohio United States 43608
    64 Toledo CCOP Toledo Ohio United States 43623
    65 Toledo Clinic Inc. Toledo Ohio United States 43623
    66 Muskogee Regional Medical Center Muskogee Oklahoma United States 74401-5075
    67 Abington Memorial Hospital Abington Pennsylvania United States 19001-3788
    68 Lehigh Valley Hospital Allentown Pennsylvania United States 18103
    69 St. Luke's Hospital and Health Network Bethlehem Pennsylvania United States 18015
    70 Doylestown Hospital Doylestown Pennsylvania United States 18901
    71 York Cancer Center/Wellspan Health York Pennsylvania United States 17403-5049
    72 Sioux Community Cancer Consortium Sioux Falls South Dakota United States 57105
    73 Thompson Cancer Survival Center Knoxville Tennessee United States 37916
    74 Baptist Memorial Hospital - Memphis Memphis Tennessee United States 38120
    75 Meharry Medical College Nashville Tennessee United States 37208-3599
    76 Methodist Regional Cancer Center Oak Ridge Tennessee United States 37830
    77 Methodist Hospitals of Dallas Dallas Texas United States 75203
    78 Scott & White CCOP Temple Texas United States 76508
    79 Cascadia Clinical Trials at St. Joseph Hospital Bellingham Washington United States 98225-1898
    80 Virginia Mason CCOP Seattle Washington United States 98101
    81 Swedish Medical Center Seattle Washington United States 98104
    82 Northwest Hospital Seattle Washington United States 98133
    83 Marshfield Clinic Marshfield Wisconsin United States 54449-5703
    84 Sinai Samaritan Medical Center Milwaukee Wisconsin United States 53233
    85 Ottawa General Hospital Ottawa Ontario Canada K1H 8L6
    86 San Juan Dr. I. Gonzalez Martinez/Centro Medico San Juan Puerto Rico 00919-1811
    87 Altamira Family Medicine San Juan Puerto Rico 00920
    88 Centro Clinico San Patricio San Juan Puerto Rico 00921
    89 Miguel Sosa Padilla, MD/San Juan City Hospital San Juan Puerto Rico 00926
    90 VAMC San Juan San Juan Puerto Rico 00927
    91 San Juan City Hospital - PR, Hematology Oncology Office San Juan Puerto Rico 00936-8344

    Sponsors and Collaborators

    • Frederick Schmitt
    • National Institute on Aging (NIA)
    • National Cancer Institute (NCI)

    Investigators

    • Principal Investigator: Frederick Schmitt, PhD, Sanders-Brown Center on Aging
    • Principal Investigator: Richard Kryscio, PhD, Sanders-Brown Center on Aging

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Frederick Schmitt, Principal Investigator, University of Kentucky
    ClinicalTrials.gov Identifier:
    NCT00040378
    Other Study ID Numbers:
    • IA0033
    • 5R01AG019241
    • NCT00780689
    First Posted:
    Jun 27, 2002
    Last Update Posted:
    Mar 14, 2018
    Last Verified:
    Mar 1, 2018
    Keywords provided by Frederick Schmitt, Principal Investigator, University of Kentucky
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 14, 2018